Furesis



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 50.0%
Cardiac Failure 12.5%
Hypothyroidism 12.5%
Ischaemic Heart Disease Prophylaxis 12.5%
Type 2 Diabetes Mellitus 12.5%
Renal Failure Acute 100.0%
Secondary
Product Used For Unknown Indication 18.7%
Hypertension 13.2%
Essential Hypertension 6.6%
Sleep Disorder 6.6%
Cardiac Failure 5.5%
Diabetes Mellitus 4.4%
Fluid Replacement 4.4%
Hyperthyroidism 4.4%
Hypokalaemia 4.4%
Polyuria 4.4%
Thrombosis Prophylaxis 4.4%
Hypothyroidism 3.3%
Ischaemic Heart Disease Prophylaxis 3.3%
Type 2 Diabetes Mellitus 3.3%
Acute Myocardial Infarction 2.2%
Agitation 2.2%
Diarrhoea 2.2%
Disorientation 2.2%
Gastrointestinal Ulcer 2.2%
Hypercholesterolaemia 2.2%
Sepsis 28.6%
Urinary Tract Infection 28.6%
Renal Failure Acute 9.5%
Swollen Tongue 9.5%
Bone Marrow Failure 4.8%
Drug Interaction 4.8%
Neutropenic Infection 4.8%
Tongue Haemorrhage 4.8%
White Blood Cell Count Decreased 4.8%
Concomitant
Drug Use For Unknown Indication 36.4%
Product Used For Unknown Indication 9.1%
Hypertension 8.2%
Pain 5.9%
Rheumatoid Arthritis 3.6%
Diabetes Mellitus 3.4%
Pneumonia 3.0%
Prostate Cancer 2.9%
Cardiac Failure 2.8%
Thrombosis Prophylaxis 2.8%
Atrial Fibrillation 2.5%
Diuretic Therapy 2.5%
Osteoporosis 2.5%
Parkinson's Disease 2.3%
Gastroenteritis 2.2%
Hypokalaemia 2.1%
Agitation 1.9%
Breast Cancer Metastatic 1.9%
Hypercholesterolaemia 1.9%
Renal Failure 1.8%
Vomiting 10.2%
Weight Decreased 10.2%
Pneumonia 8.0%
Pyrexia 6.8%
Pancytopenia 5.7%
Rhabdomyolysis 5.7%
Melaena 4.5%
Pulmonary Embolism 4.5%
Sudden Death 4.5%
White Blood Cell Count Increased 4.5%
Wrong Drug Administered 4.5%
Arrhythmia 3.4%
Ascites 3.4%
Hemiparesis 3.4%
Hyponatraemia 3.4%
Myocardial Infarction 3.4%
Organising Pneumonia 3.4%
Pancreatitis 3.4%
Stevens-johnson Syndrome 3.4%
Tachycardia 3.4%
Interacting
Hypertension 50.0%
Cardiac Failure 12.5%
Diabetes Mellitus 12.5%
Hypothyroidism 12.5%
Ischaemic Heart Disease Prophylaxis 12.5%
Renal Failure Acute 100.0%